Side Effects: Signals in Strange Places - Report - MDSpire

Side Effects: Signals in Strange Places

From breathier speech to breastfeeding history, metamaterial eye coils, and antifibrotic GLP-1 effects in mice, this week’s studies remind us that the most interesting signal is often hiding somewhere clinicians were not looking.

  • By

  • Kerri Miller

  • July 13, 2026

  • 5 min

Share

Clinical Report: Voice Changes as Early Indicators of Asthma Exacerbations

Overview

The TACTICAS study found that voice changes can signal asthma or COPD exacerbations before medication is administered. Acoustic features such as vowel length and pitch variations were significantly altered at exacerbation onset.

Background

Asthma and chronic obstructive pulmonary disease (COPD) exacerbations can lead to significant morbidity and mortality. Early detection of exacerbations is crucial for timely intervention and management. The TACTICAS study explores the use of voice changes as a biomarker for identifying exacerbations.

Data Highlights

FeatureChange at Exacerbation Onset
Sustained Vowel LengthShorter
Median PitchDecreased
Breathiness MeasuresIncreased
Irregular Vocal-Fold VibrationIncreased

Key Findings

  • Voice changes were observed on day 1 of exacerbation onset in some participants.
  • 13 of 39 acoustic features showed significant differences at exacerbation onset.
  • Most exacerbations recorded were mild to moderate, with only 3 classified as severe.
  • The symptom questionnaire detected 30 of 38 confirmed exacerbations but missed 8.
  • Participants completed voice tasks more consistently than symptom questionnaires.

Clinical Implications

Further research is needed to validate these findings across diverse populations and settings.

Conclusion

The TACTICAS study highlights the potential of voice changes as indicators of respiratory exacerbations.

Related Resources & Content

  1. European Respiratory Society, ERJ Open Research, 2026 -- Voice as biomarker for early exacerbation detection in asthma and COPD: the TACTICAS study
  2. Frontiers in Medicine — Signals of drug-related retinal artery occlusion: a multi-country retrospective study from a spontaneous reporting system
  3. Drug Safety — Communication of Adverse Drug Reaction Signals by Pharmacovigilance Entities: A Comprehensive Review of Global Research
  4. Drug Safety — Innovative Computational Methods for Signal Detection in Pharmacovigilance: Advancing Towards Integrated and Semantically-Enriched Frameworks
  5. the analytical scientist — Mass Spec Roundup: Hidden Signals and Sharper Reads
  6. 2026 GINA Strategy Report - Global Initiative for Asthma - GINA
  7. Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement - PMC
  8. Voice as biomarker for early exacerbation detection in asthma and COPD: the TACTICAS study | European Respiratory Society
  9. Respiratory-Responsive Vocal Biomarker for Asthma Exacerbation Monitoring: Prospective Cohort Study
  10. Cough biomarkers for diagnosis and monitoring of respiratory disease: a systematic review | European Respiratory Society
  11. A cough sound-based deep learning algorithm for accessible prompt detection of chronic obstructive pulmonary disease with smartphones | npj Primary Care Respiratory Medicine

Original Source(s)

Side Effects: Signals in Strange Places

  • by Kerri Miller

  • July 13, 2026

Related Content

FDA Approves Atacicept for IgA Nephropathy

The approval was based on reduced proteinuria, and an ongoing trial is required to determine whether atacicept slows long-term kidney function decline.

Updated COVID Shot Linked to Added Protection

Updated 2025-2026 vaccination was linked to added protection in a CDC-funded analysis that became part of a broader debate over routine vaccine monitoring.

Why Practices Join Hospital Systems

Interviews with hospital leaders and employed physicians highlighted financial pressures, perceived care-integration benefits, and unresolved operational tensions following acquisition.